These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11222981)

  • 1. Elicitation of predictable immune responses by using live bacterial vectors.
    Drabner B; Guzmán CA
    Biomol Eng; 2001 Mar; 17(3):75-82. PubMed ID: 11222981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
    Medina E; Guzmán CA
    Vaccine; 2001 Feb; 19(13-14):1573-80. PubMed ID: 11166877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F; Ulmer JB
    J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances with recombinant bacterial vaccine vectors.
    Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
    Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
    Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
    Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G; Spreng S; Gentschev I; Goebel W
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation.
    Beyer T; Herrmann M; Reiser C; Bertling W; Hess J
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):287-302. PubMed ID: 12455402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A; zur Lage S; Garbe AI; Chakraborty T; Weiss S
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):341-9. PubMed ID: 10727890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Daniels J; Hess J; Kaufmann SH; Goebel W
    J Biotechnol; 2000 Sep; 83(1-2):19-26. PubMed ID: 11000455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV.
    Vecino WH; Morin PM; Agha R; Jacobs WR; Fennelly GJ
    Immunol Lett; 2002 Jul; 82(3):197-204. PubMed ID: 12036602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.